Valuation Virax Biolabs Group Limited

Equities

Real-time Estimate Cboe BZX Other stock markets 16:00:55 16/01/2026 GMT			5-day change	1st Jan Change
0.3190 ^USD	+1.59%		-14.36%	-10.35%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2023	2024	2025	2026	2027
Capitalization ¹	10.81	1.693	4.95	2.331	-
Change	-	-84.34%	192.29%	-52.91%	-
Enterprise Value (EV)	10.81	1.693	4.95	2.331	2.331
Change	-	-84.34%	192.29%	-52.91%	0%
P/E ratio	-	-0.21x	-0.7x	-0.79x	-1.31x
PBR	-	-	-	-	-
PEG	-	-	0x	0x	0x
Capitalization / Revenue	1,263x	-	782x	583x	583x
EV / Revenue	0x	-	0x	583x	583x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-0x	-	-0x	-0.45x	-0.45x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-	-3.36	-1.62	-0.4	-0.24
Distribution rate	-	-	-	-	-
Net sales ¹	0.00856	-	0.00633	0.004	0.004
EBITDA	-5.733	-	-	-	-
EBIT ¹	-5.733	-	-6.163	-5.184	-5.198
Net income ¹	-5.457	-6.734	-6.061	-4.942	-5.198
Net Debt	-	-	-	-	-
Reference price ²	6.9540	0.7170	1.1400	0.3140	0.3140
Nbr of stocks (in thousands)	1,555	2,362	4,342	7,423	-
Announcement Date	14/06/23	20/08/24	02/07/25	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VIRAX BIOLABS GROUP LIMITED	-0.79x	-	-	-	2.33M
LONZA GROUP AG	39.23x	5.69x	19.06x	0.88%	49.36B
IQVIA HOLDINGS INC.	33.98x	3.36x	14.37x	-.--%	41.09B
BEONE MEDICINES AG	103.5x	6.63x	66.63x	-.--%	37.43B
CELLTRION, INC.	55.58x	11.4x	31.68x	0.35%	31.37B
REVOLUTION MEDICINES, INC.	-22.06x	6405.73x	-20.93x	-.--%	23.83B
MEDPACE HOLDINGS, INC.	41.75x	6.77x	30.78x	-.--%	17.41B
EUROFINS SCIENTIFIC SE	28.03x	2.24x	10.03x	0.87%	14.86B
ICON PUBLIC LIMITED COMPANY	27.09x	2.1x	10.74x	-.--%	13.94B
Average	34.03x	805.49x	20.29x	0.26%	25.48B
Weighted average by Cap.	43.37x	670.98x	23.35x	0.29%